terbutaline has been researched along with Pervasive Child Development Disorders in 2 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caritis, SN | 1 |
| Simhan, HN | 1 |
| Rodier, P | 1 |
| Miller, RK | 1 |
| Brent, RL | 1 |
2 other studies available for terbutaline and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Beta adrenergic agonists and neonatal outcome.
Topics: Adrenergic Agonists; Animals; Child; Child Development Disorders, Pervasive; Female; Humans; Pregnan | 2010 |
Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?
Topics: Child Development Disorders, Pervasive; Female; Humans; Infant, Newborn; Obstetric Labor, Premature; | 2011 |